Brown Recluse Spider Bite Mediated Hemolysis: Clinical Features, a Possible Role for Complement Inhibitor Therapy, and Reduced RBC Surface Glycophorin A as a Potential Biomarker of Venom Exposure
Open Access
- 27 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9), e76558
- https://doi.org/10.1371/journal.pone.0076558
Abstract
The venom of Loxosceles reclusa (Brown Recluse spider) can cause a severe, life-threatening hemolysis in humans for which no therapy is currently available in the USA beyond supportive measures. Because this hemolysis is uncommon, relatively little is known about its clinical manifestation, diagnosis, or management. Here, we aimed to clarify the clinical details of envenomation, to determine the efficacy of the complement inhibitor eculizumab to prevent the hemolysis in vitro, and to investigate markers of exposure to Brown Recluse venom. We performed a 10-year chart review of cases of Brown Recluse spider bite-mediated hemolysis at our institution. We also designed an in vitro assay to test the efficacy of eculizumab to inhibit hemolysis of venom exposed red blood cells. Finally, we compared levels of CD55, CD59 and glycophorin A on venom exposed versus venom-naïve cells. Most victims of severe Brown Recluse spider mediated hemolysis at our institution are children and follow an unpredictable clinical course. Brown Recluse spider bite mediated hemolysis is reduced by 79.2% (SD=18.8%) by eculizumab in vitro. Erythrocyte glycophorin A, but not CD55 or CD59, is reduced after red blood cells are incubated with venom in vitro. Taken together, our laboratory data and clinical observations indicate that L. reclusa venom exposure results in non-specific antibody and complement fixation on red blood cells, resulting in complement mediated hemolysis that is curtailed by the complement inhibitor eculizumab in vitro. Glycophorin A measurement by flow cytometry may help to identify victims of L. reclusa envenomation.Keywords
This publication has 33 references indexed in Scilit:
- Acute Generalized Exanthematous Pustulosis and Coombs‐Positive Hemolytic Anemia in a Child Following Loxosceles reclusa EnvenomationPediatric Dermatology, 2011
- Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutinationTransfusion, 2010
- The Distribution of Brown Recluse Spiders in the Southeastern Quadrant of the United States in Relation to Loxoscelism DiagnosesSouthern Medical Journal, 2009
- Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin diseaseBlood, 2009
- LoxoscelismClinics in Dermatology, 2006
- Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA)Biochemical Journal, 2005
- Loxosceles Sphingomyelinase Induces Complement-Dependent Dermonecrosis, Neutrophil Infiltration, and Endogenous Gelatinase ExpressionJournal of Investigative Dermatology, 2005
- Bites of Brown Recluse Spiders and Suspected Necrotic ArachnidismThe New England Journal of Medicine, 2005
- Severe Autoimmune Hemolytic Anemia Associated with IgM Warm Autoantibodies Directed against Determinants on or Associated with Glycophorin AVox Sanguinis, 1997
- Incompatibility associated with the bite of a brown recluse spider (Loxosceles reclusa)Transfusion, 1983